Clinical Trial Update: Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients

View source ↗

Summary

The clinical trial evaluating a tailored beta-catenin mutational approach for extra-abdominal sporadic desmoid-type fibromatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Desmoid-type Fibromatosis | Status: COMPLETED